UA98831C2 - Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome - Google Patents

Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome

Info

Publication number
UA98831C2
UA98831C2 UAA201008981A UAA201008981A UA98831C2 UA 98831 C2 UA98831 C2 UA 98831C2 UA A201008981 A UAA201008981 A UA A201008981A UA A201008981 A UAA201008981 A UA A201008981A UA 98831 C2 UA98831 C2 UA 98831C2
Authority
UA
Ukraine
Prior art keywords
lasting
treatment
long
bronchial asthma
asthma associated
Prior art date
Application number
UAA201008981A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марьяна Васильевна Ростока-Резникова
Марианна Ивановна Товт-Коршинская
Иван Васильевич Чопей
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAA201008981A priority Critical patent/UA98831C2/en
Publication of UA98831C2 publication Critical patent/UA98831C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to medicine and can be used for the treatment of patients with long-lasting moderately severe bronchial asthma associated with dyspeptic syndrome. The method disclosed involves combined use of monitoring therapy and antihomotoxical preparation Galium-Heel intended for the correction of oxidant homeostasis indices.
UAA201008981A 2010-07-19 2010-07-19 Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome UA98831C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201008981A UA98831C2 (en) 2010-07-19 2010-07-19 Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201008981A UA98831C2 (en) 2010-07-19 2010-07-19 Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome

Publications (1)

Publication Number Publication Date
UA98831C2 true UA98831C2 (en) 2012-06-25

Family

ID=50847442

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201008981A UA98831C2 (en) 2010-07-19 2010-07-19 Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome

Country Status (1)

Country Link
UA (1) UA98831C2 (en)

Similar Documents

Publication Publication Date Title
AU2018253544A1 (en) Methods for treating or preventing asthma by administering an IL-4R antagonist
NZ713202A (en) Diagnosis and treatments relating to th2 inhibition
IN2014KN00996A (en)
MX2012007806A (en) Pharmaceutical compositions for oral administration of insulin peptides.
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
GB201318950D0 (en) Deployment Catheter
MY165086A (en) Formulations of rifaximin and uses thereof
MX352824B (en) USE OF LEVOCETIRIZINE and MONTELUKAST IN THE TREATMENT OF INFLUENZA, COMMON COLD and INFLAMMATION.
BRPI1005154A2 (en) "therapeutic composition, method for inhibiting or reducing the production of superoxide ions, nitric oxide (n), tumor necrosis factor alpha (tnf-alpha) and / or prostaglandin e2 (pge2) in a mammalian subject, methods of treatment and use of a combination"
EP2749280A3 (en) Combination of glycopyrronium and formoterol
IN2014MN00333A (en)
WO2012023623A3 (en) Agent for treatment of hunter syndrome
WO2012047951A3 (en) Human lung stem cells and uses thereof
MY173215A (en) Acetylcysteine compositions and methods of use thereof
EA201490378A1 (en) TREATMENT OF MULTIPLE SCLEROSIS USING THE COMBINATION OF LACHINIMODA AND INTERFERON-β
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
WO2012093258A3 (en) Irf5- related treatment and screening
MX2014000066A (en) High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis.
MD4369C1 (en) Use of glycopyrrolate for treating tachycardia, unit dose, delivery device, method of treatment and prophylaxis of tachycardia
MX356317B (en) Treatment of symptoms associated with female gastroparesis.
NZ607900A (en) Compound composition for inhalation used for treating asthma
EP2442657A4 (en) Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
WO2016025671A3 (en) Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist
IN2014DN09383A (en)
UA98831C2 (en) Method for the treatment of long-lasting bronchial asthma associated with dyspeptic syndrome